Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: Intranasal Insulin for Treatment of Alcohol Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

Brown University is conducting a Phase 1/2 study to evaluate intranasal insulin for Alcohol Use Disorder. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intranasal insulin (insulin)

Snippet

Sponsor: Brown University | Conditions: Alcohol Use Disorder | Phase 1, Phase 2 | Status: RECRUITING